GCAN — TRAFALGAR INTERNATIONAL, INC.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1695473 ·
Last close
$1.61
Market Cap
$1.60M
52W High
$2.50
52W Low
$0.76
ADV30
1,587
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | 0 | -11,555 | 611,378 | 111 | 111 | 12,239 |
| Mar 2026 | 0 | 0 | -33,376 | -33,376 | 1,439 | 1,439 | 776,464 |
| Dec 2025 | 0 | 0 | -53,806 | 337,757 | 815 | 815 | 742,464 |
| Sep 2025 | 0 | 0 | -37,412 | -36,099 | 21,355 | 21,355 | 1,129,697 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-53,374
Investing CF
$0
Financing CF
$5,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.04
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-5,025,333
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-261,905
Pretax Income TTM
$-122,571
Interest Exp TTM
$-135,966
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -183,005 | -331,612 | 815 | 742,464 | -741,649 | -60,153 |
| Dec 2024 | 0 | -156,276 | -179,041 | 57,785 | 898,058 | -840,273 | -109,491 |
| Dec 2023 | 0 | -175,364 | -188,402 | 172,276 | 833,508 | -661,232 | -103,171 |
| Dec 2022 | 0 | -177,035 | -360,268 | 280,447 | 825,277 | -544,830 | -107,490 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ATXI | AVENUE THERAPEUTICS, INC. | $1.65M | $0.50 | — |
| AGNPF | Grey Matters Health Inc. | $1.66M | $0.31 | — |
| LIFD | LFTD PARTNERS INC. | $1.48M | $0.10 | — |
| PPCB | Propanc Biopharma, Inc. | $1.44M | $0.63 | — |
| RNAZ | Transcode Therapeutics, Inc. | $1.79M | $1.69 | — |
News headlines (Yahoo Finance, 1h cache)
Trafalgar International Launches U.S. Public Company Platform for Financial Services and Strategic Investment
2026-08-17 19:08 · Yahoo
GCANRx Announces Relisting To OTCQB Market Tier
2025-12-03 12:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.